Issue link: http://itf.uberflip.com/i/464146
77 ITF Women's Circuit Procedure for investigating a potential case of female hyperandrogenism 4. If a Request is admissible, all relevant available documents of the player under investigation (the "Player"), including (but not limited to) medical history, sex hormone levels, diagnosis and treatment shall be provided by the Player and/or her physician to the Executive Director, Science & Technical. The Executive Director, Science & Technical shall provide this information to the Expert Panel such that the Expert Panel is not able to identify the name of the Player. 5. The Expert Panel may request that the Player and/or her physician provide further information and/or that the Player undergo further examination(s) to determine whether female hyperandrogenism is present and can be considered to confer a competitive advantage. 6. The Expert Panel may provide the Player and/or her physician with an opportunity to be heard before the Expert Panel prior to making its determination. If the Player and/or her physician refuses to (a) provide any information requested and/or (b) undergo any examination requested by the Expert Panel, the Expert Panel may recommend to the Executive Director, Science & Technical that the Player is suspended from competition pending compliance with the refusal. 7. The Expert Panel shall examine all available information and establish: a. Whether the Player's androgen level, measured by reference to testosterone levels in serum, is within the male range, and, if so; b. Whether such hyperandrogenism is 'functional' or not 1 . Determination 8. On completion of its investigation, the Expert Panel shall determine that: a. The Player does not have female hyperandrogenism, in which case the case shall be closed, and the Player shall be eligible to compete in women's Pro Circuit events. Such decision is final and binding and not subject to appeal, or; b. The Player has female hyperandrogenism that does not confer a competitive advantage because it is non-functional or the androgen level is below the male range, in which case the case shall be closed, and the Player shall be eligible to compete in women's Pro Circuit events. Such decision is final and binding and not subject to appeal, or; 1 There are some cases of hyperandrogenism that do not confer a competitive advantage because of 'non-functional' androgen receptors.